Hypothetical Estimands for Treatment-Affected Events

What Does “If the Event Had Not Occurred” Mean?

A treatment-affected event can change both the care a participant receives and the outcome that follows. Rescue medication is a clear example: it may be given because symptoms worsen, and it may then change the outcome measured at the planned endpoint. If the scientific question concerns the outcome without rescue, the observed outcome after rescue does not directly answer it. A hypothetical estimand makes the missing counterfactual question explicit: what would the outcome have been under a defined intervention that prevented rescue?

This is an estimand choice, not a method for filling in an unrecorded value. In particular, it does not mean that participants who receive rescue are simply removed from the analysis. Their outcomes under the no-rescue condition are counterfactual, and identifying an average of those outcomes requires assumptions beyond randomization of the original treatment.

The superscript \(0\) is not a claim that the event indicator is naturally zero for everyone. It denotes a hypothetical intervention. The intervention must say what happens instead: for example, rescue medication is withheld while assigned treatment and scheduled assessments continue. If a participant discontinues assigned treatment, a hypothetical strategy might specify continued dosing, but that is a different and potentially less plausible intervention. “As if the event had not happened” is not sufficiently precise unless the alternative course of care and treatment are clear.

The outcome variable, time point, summary measure, target population, and treatment conditions still need to be fixed. In an adaptive trial, changes to allocation or other operating features do not by themselves change this target. The estimand remains the contrast of the specified treatment conditions under the specified no-event intervention; the analysis must still account for the actual design.

Counterfactual Definition and Identification

Let \(A\) denote randomized treatment, \(E\) indicate whether the event occurs before the endpoint, \(L\) be measured information available before the event, and \(Y\) be the endpoint. For a one-time event, \(Y^{a,0}\) is the outcome that would be observed if the participant received treatment \(a\) and the event were prevented. The treatment-specific hypothetical mean is \(\mu_a^{hyp}=\mathbb E(Y^{a,0})\). A mean difference is then \(\Delta^{hyp}=\mu_1^{hyp}-\mu_0^{hyp}\). For a binary endpoint, the same construction can target a risk or risk difference rather than a mean.

Randomization supports comparisons of assigned treatment strategies, but it does not randomize who experiences rescue or discontinuation. Participants who experience an event may have worse prognosis than those who do not. Therefore, comparing observed outcomes only among event-free participants can be biased, even in a randomized trial. To identify the hypothetical mean, the analysis needs assumptions about the event process and the unobserved outcomes.

These conditions are substantive, not guaranteed by a statistical formula. Conditional exchangeability is especially demanding: all important common causes of the event and the hypothetical outcome must be measured and included in \(L\). The event itself can be treatment-affected, and its predictors can differ by treatment. If time-varying predictors both affect later event occurrence and are affected by treatment, a one-time adjustment formula is not enough; a longitudinal identification and analysis strategy is needed.

A Short Standardization Derivation

For a single event and baseline covariates \(L\), the hypothetical mean can be written as a standardized average of outcomes among participants who remained event-free. The argument makes clear why both assumptions and adjustment matter.

The first equality is the definition of the target mean. The second averages over the target population’s covariate distribution. The third uses conditional exchangeability: within \(L\) strata, the event-free group represents the hypothetical outcomes for the full stratum. The final equality uses consistency for those who actually remain event-free and receive treatment \(a\). Positivity is needed so that each conditional mean on the last line can be learned from data. In a more complex event process, the corresponding identification formula must account for the sequence of histories and event decisions; this short derivation does not justify treating longitudinal events as a single baseline adjustment.

Two Ways to Estimate a Simple Hypothetical Mean

When \(L\) is a manageable set of baseline variables, standardization estimates the event-free mean within each stratum and averages those means using the target population’s distribution of \(L\). A regression model can implement this calculation, but the target is still the standardized mean, not merely a regression coefficient. The model must represent the outcome relationships adequately, and strata with no event-free participants cannot supply their conditional outcome mean from the data.

An alternative is inverse-probability weighting. Each event-free participant is weighted by the inverse of their estimated probability of remaining event-free, conditional on measured predictors. Participants who resemble people unlikely to remain event-free receive greater weight, so the weighted event-free group can represent the full target population. This approach also relies on correct estimation of event-free probabilities, conditional exchangeability, and positivity. It is not a way to avoid those assumptions.

Diagnostics, Alternatives, and Limits

A useful analysis checks whether the data can support the counterfactual comparison before reporting a number. Examine event-free counts and estimated probabilities across treatment groups and important prognostic strata. Very small probabilities indicate a positivity problem: the observed event-free participants may not represent the participants whose counterfactual outcomes the estimand requires. Check outcome and event models for implausible predictions and compare reasonable model specifications. Sensitivity analyses should assess how conclusions change under plausible departures from conditional exchangeability or model assumptions.

The main alternative discussed in the earlier material on treatment-policy estimands is to retain outcomes after the event as part of the treatment condition’s outcome. That answers what happens under the assigned treatment strategy, including the event and its consequences. A hypothetical estimand instead asks what would happen under the specified event-prevention condition. Neither is universally preferable; the choice depends on the clinical question. A composite approach can also define an outcome that incorporates the event, but it changes the outcome question rather than recovering the no-event counterfactual.

A hypothetical intervention can be scientifically informative even when it is difficult or impossible to implement literally. However, the more the intervention conflicts with clinical practice—for example, preventing discontinuation despite serious toxicity—the more carefully its interpretation must be qualified. A well-fitted model cannot make an ill-defined or clinically incoherent counterfactual meaningful. Nor does a hypothetical estimand automatically solve missing-data problems: an event-free outcome may be unobserved precisely because the event occurred, and the counterfactual must be inferred under stated assumptions.